Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient

Dermatitis. 2024 Jan-Feb;35(S1):S109-S110. doi: 10.1089/derm.2023.0181. Epub 2023 Aug 10.

Authors

Afsoon Ghafari-Saravi¹, Teri M Greiling¹

Affiliation

¹ Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

PMID: 37566480
DOI: 10.1089/derm.2023.0181

No abstract available

MeSH terms

Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal, Humanized / adverse effects
Dermatitis, Atopic* / drug therapy
Humans
Immunocompromised Host

Substances

dupilumab
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal